Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-02-11 @ 8:57 AM
Study NCT ID:
NCT00550459
Status:
COMPLETED
Last Update Posted:
2011-04-28
First Post:
2007-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
156-04-246
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dorothee Oberdhan, Manager, Global Clinical Development
Old Organization:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |